Managing risks in a project

July 29th, 2010 by admin No comments »
Retweet

Pharmaceutical manufacturing is frequently faced with changes. Risks have hence become an integral part of any manufacturing project. Some common situations that are a potential peril include addition of a new user to an existing and validated WFI system, addition of a production shift, renovation of an existing facility, substitution of a supplier of printed packaging material, etc. Risk is not only limited to probability of a harm, it extends to include severity, detection, prevention and elimination of the harm.

Managing risks

Risk management has acquired new dimensions as better tools for assessment, reassessment, control and monitoring are now available. ICH Q9 elaborates ‘Quality risk management’.  The identification, analysis, evaluation, reduction, acceptance, communication and review are critical steps in risk management. Risk management is not devoid of risks! A huge possibility is that only the ‘knowns’ are assessed. There is a need to have a systematic approach that can help think beyond what is known. The first crucial step is to define the problem and the affiliated pertinent assumptions. Next assemble available data and identify the resources, timelines and deliverables. Choose the best tools to manage risks. No single tool or set of tools qualifies best for every situation.

Using tools and techniques to manage risks

Techniques like flowcharts, process mapping, check sheets and ishikawa (fish bone) diagrams are employed in managing risks. The latter are particularly useful in scrupulously planning drying, compression, granulation, etc. in tablet manufacturing.

Controlling risks

Risk control implies the introduction of controls in facility, equipment, process, and/or product design which reduce the risk. Risk should decrease as knowledge of product and process build up in advancing product lifecycles.

Accepting risks

Risks should be accepted with preparedness for action plan and rectification to achieve desired goals. Absolute risk eradication is more a hypothesis as residual risk is a consequence of even the best managed situations and risks.

Communicating risks

It is good to be vocal about risks. The project teams should be trained to anticipate, accept and attenuate risks. A clear communication is a must to mitigate risks. Above all, risks should be appropriately communicated to all stakeholders.

Reviewing risks

A vigilant team managing a risk will always want to reiterate and revisit the major events in the management plan. Lessons learned should be reviewed, documented and shared. This can help to assemble data, generate information and synthesize knowledge.

Clearly, risk management involves diverse and multifarious approaches.

For more info on the Prescription Pharma Support’s trainings and workshops write to us atpharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Project Management

Event Name Project Management and Change Control – Get it Right The First Time

Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker

Date & Venue : 29-30 July 2010, Harris Hotel Tebet, Jakarta

More Infohttp://www.pharmasupport.in/latest-pharma-events.html

Contact: Mr. Rony Rianto on + 62 81808610171 or rianto@inovamitra.com OR Mr. Rizwan Rustam on + 62 2198949630 or rizwan.rustam@inovamitra.com

Download:http://ow.ly/2hC4X

The regulatory perspectives of project management

July 28th, 2010 by admin 4 comments »
Retweet

Manufacturing projects in pharmaceutical industry are governed by regulations. The FDA and EU-GMP promulgate guidelines for pharmaceutical manufacturers and distributors. The manufacturing, processing, packing or holding of a drug product are managed in accordance with guidelines for the same. The guidance Q8 (R2) by the International Conference on Harmonization (ICH) for Pharmaceutical Development aims “to design a quality product and its manufacturing process to consistently deliver the intended performance of the product.”  Q9 is a systematic approach to quality risk management. It is based on principles that risk to quality should be based on scientific knowledge and the efforts, formality and documentation of the same should be commensurate with the level of risk. It outlines the tools of quality risk management applied to development, manufacturing, distribution, and the inspection and submission/review processes throughout the lifecycle of drug substances, drug products, biological and biotechnological products. ICH Q10 is a model for a pharmaceutical quality system that can strengthen link between pharmaceutical development and manufacturing activities and can be implemented throughout the stages of a product lifecycle. The scope extends to technology transfer, commercial manufacturing and product discontinuations. The effectiveness of the pharmaceutical quality system is usually evaluated during a regulatory inspection at the manufacturing site. ICH Q11 for ‘Development and manufacture of drug substances’ is designed to provide examples as appropriate for describing the principles and concepts which are included in ICH Q8, Q9, and Q10. It applies to drug substances as defined in the scope of the ICH Guideline Q6A (“NCE”) and ICH Guideline Q6B (“Biotechnological/biological“).

Section 211 of CFR clearly states that there shall be written procedures for “production and process control designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess.” Any deviations from these procedures should be drafted, reviewed, and approved by the appropriate organizational units and also reviewed and approved by the quality control unit. Clearly, good manufacturing involves efficient management for issues relating to building and facilities, production and process controls, equipment and control of microbiological contamination.

Any project for manufacturing has the potential to be a deviation from prescribed guidelines and project plans. It is prudent to anticipate deviations, avoid them as far as possible, and to record and justify them. The management of manufacturing projects extends to quality management. This should achieve product realization and establish and maintain a state of control. Quality risk management ensures continued suitability and capability of processes. It helps to identify and prioritize areas for continual improvement.

Corrective and preventive actions (CAPA) facilitate management of change in projects. Periodic assessment of efficacy of projects should be done and any problems identified necessitate a CAPA.Monitoring of internal and external factors impacting quality management system include emerging regulations and guidance, innovations, changing business environment and objectives and changes in product ownership.

There can be several reasons besides change in quality management policies and objectives that can instigate the need for a project. These include allocation and reallocation of resources, change in operations and control, and management review and actions. The single driving force for a project is ‘change’ and its apprehended unintended consequences. ICH Q7 emphasizes that “A formal change control system should be established to evaluate all changes that may affect the production and control of the intermediate or API.” It further requires for change to be classified, justified, documented, and potential impacts to be determined.

International Society for Pharmaceutical Engineering (ISPE) has enunciated guidelines to introduce innovation and excellence in pharmaceutical technology, processes and operations. It has made onerous efforts to help the industry meet challenges of ICH guidelines. It is imperative to familiarize and comprehend emerging inspection trends and take up projects in accordance with guidelines to meet the requirements of good manufacturing practices.

For more info on the Prescription Pharma Support’s trainings and workshops write to us at pharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Project Management

Event Name Project Management and Change Control – Get it Right The First Time

Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker

Date & Venue : 29-30 July 2010, Harris Hotel Tebet, Jakarta

More Infohttp://www.pharmasupport.in/latest-pharma-events.html

Contact: Mr. Rony Rianto on + 62 81808610171 or rianto@inovamitra.com OR Mr. Rizwan Rustam on + 62 2198949630 or rizwan.rustam@inovamitra.com

Download:http://ow.ly/2hC4X

Project management: Starting a new project

July 28th, 2010 by admin No comments »
Retweet

A project implies ‘plan for a scheme or undertaking’. Projects are driven by change which is perhaps the only constant. It is important to register that projects are driven by a need and facilitate a change or implementation of a change. Projects are thus designed to promote change and innovation.

When initialing new projects forethought about timelines, budgets, and people involved is a must. A project should be well planned and should be driven by a clear statement of objectives. Always know what tangible product can be obtained from a project. The entire task can be broken into phases. Each phase should have a defined timeline and an objective.  At the very start, budget and authorization of payments should be outlined. The proposals for a budget should be attractive, realistic and justified. Formulate a plan and translate it into a timely action to achieve the desired objectives. Plans include risk assessment & management plan, budget, staffing, quality assurance plans and other schedules. Initiation requires use of tools like project charter, business plan, project framework (or overview), business case justification, and milestones reviews.

An experienced head will always be prepared to accept that nothing, neither timelines nor budgets will work out exactly. So one should be prepared to meet change. Build flexibility in a project plan. Also build periodic reviews, operational, financial, etc. to steer the project in the right direction. Avoid rework. Work right in first attempt.

Project launch begins with a kick-off meeting with sponsor and project team. The meeting will include discussions on methodology, principles and objectives. Scope of a project will be decided by the sponsor. Since people are involved in projects it is desirable to train teams on project management. A session for such trainings can be scheduled soon after launch of a project. The project manager is solely responsible for the conduct and success of a project. He/she should have remarkable communication and problem solving skills. The project performance should be measured, evaluated and corrected all throughout the life cycle. The first step to project success is to begin it right. Well begun is half done.

For more info on the Prescription Pharma Support’s trainings and workshops write to us atpharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Project Management

Event Name : Project Management and Change Control – Get it Right The First Time
Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker
Date & Venue : 29-30 July 2010, Harris Hotel Tebet, Jakarta
Contact: Mr. Rony Rianto on + 62 81808610171 or rianto@inovamitra.com OR Mr. Rizwan Rustam on + 62 2198949630 or rizwan.rustam@inovamitra.com

Monitoring and testing in pharmaceutical water systems

July 27th, 2010 by admin No comments »
Retweet

Monitoring and testing are essential components to keep the water systems ‘good for use’ in pharmaceutical and other industries. Testing plans and the obtained results have gained credit from regulatory inspectors. Water chosen for manufacture, distribution or use has specific technical requirements. Quality of feedwater and specifications of water for injection have special mention in the US and European pharmacopoeias.

The new pharmacopoeial guidelines for purified water and water for injections are concentrated on the measurement of conductivity and total oxidisable carbon (TOC) as the basic measures of water quality. Some specific waters need testing for heavy metal and endotoxins to meet specific product or regulatory requirements. From the initial stage of feed water to final point of use, water quality should be determined at each stage in treatment, storage and distribution. Sanitization or sterilization regimens should be determined and implemented.

Material selection is vital in design and validation processes. A carefully chosen material should meet some key objectives like easy fabrication to high expected standards, minimal corrosion potential, elimination of biofilms, aesthetically clean surfaces, no retention of cleaning or disinfecting agents, etc. Choice of both plastics and steel should be customized according to type and specifications of different water systems.

Water systems should be pressure and leak tested. For an integrated system start-up, testing and reporting the “3 phase” approach of FDA has got a welcome response in industry. Phase 1 is of rigorous performance monitoring and water quality testing that aims to develop and refine operational procedures. Phase 2 involves a two to four week testing program on the established procedures. Phase 3 is a long term testing carried over twelve months. It determines the stability and reliability of the systems. If experiences in phase 3 are encouraging the plant can be moved to a normal monitoring mode.

One of the essential prerequisites of a good testing is to determine the location, volumes and frequencies of samples to be tested. Addition test points when required should be circumspectly inserted in systems at appropriate locations. Essential system features that form an integral part of “Design Qualification or Review” should be known and established. Meeting design requirements alone can translate into an effective installation that can meet the criteria for the “Installation Qualification”. Documents, guides and standards needed to establish a good engineering practice should be secured. “Operational and Performance Qualification” steps should be conscientiously implemented to make the systems as ideal as possible. Stringent and successful testing and monitoring of water quality can attest waters to be best for use in manufacturing processes.

For more info on the Prescription Pharma Support’s trainings and workshops write to us atpharmasupport@gmail.com or visit www.pharmasupport.in or Follow us onwww.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Pharmaceutical Water systems: Finding the right one

July 27th, 2010 by admin 5 comments »
Retweet

The ‘best fit’ in pharmaceutical water systems is perhaps not possible. A common challenge in pharmaceutical and biotechnological industries is to match the right water system to the production usage requirements and expectations. Several new unconventional modular system designs have been introduced that offer adaptability to changing production environments.

This has traditionally been done on basis of historical experience of the engineers involved in the water systems.  A constellation of suppliers offer ranges of water purification equipment. Of these only a few offer holistic designs, covering ‘raw water’ to ‘point of use’.

Pharmaceutical water systems have been confounding as these are multi-disciplinary involving subjects like quality assurance and control, chemistry and microbiology, monitoring, testing, regulatory compliance and validation. Besides these there are other key concerns like the configuration of loops, optimum operating temperatures, choice of sanitisation methods, balancing of flow, use of pumps, etc. The generation of water, storage, distribution, quality and flow rates may be subtle requirements but make a difference to the overall systems. Though the water systems involve no rocket science, yet there has been little science applied to managing these systems. One huge cause of this can be that the users are not aware of what specifications are desired in the systems.

Only if users have aptitude to comprehend their needs can they be able to design and choose the most efficient and effective water systems. Training on water systems is hence important so that all involved in management of such systems can be suitably skilled and proficient. The user specific requirements are unique to each system and engineering principles need to be applied on a holistic basis to all. Practices of documenting the requirements and solutions are desirable as the industry has only laconic support for the same at present.  Further tailored practices are needed to build robust systems as no two systems can be identical.

For more info on the Prescription Pharma Support’s trainings and workshops write to us atpharmasupport@gmail.com or visit www.pharmasupport.in or Follow us onwww.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Managing rouge in pharmaceutical water systems

July 26th, 2010 by admin 2 comments »
Retweet

Rouge in pharmaceutical waters systems needs management, monitoring and control. To minimize the effects of rouge some practices have to be identified and justified scientifically. Both systems designs and operations need specifications to contain the formation and growth of rouge. The pharmaceutical and biotechnological industries have continuously sought to increase awareness on management of rouge.

System designs influence rouge. Firstly material should be carefully selected and specified. Employment of 316/L grade stainless steel throughout the water systems, electropolished vessels and good mechanical polish for pipework (0.4 – 0.6 Ra typically) helps build superior designs for containment of rouge. It is laudable to obtain material certification verification for pipework and all water contact fittings. The welding procedures should be consistent in quality and correct in specifications. Degreasing and passivation at regular intervals and confirmation of successful passivation (ferroxyl test pieces) are desirable.

Nitrogen or other inert atmospheres can deplete oxygen in hot systems and should be avoided over vessels. Since rouge has been attributed to high temperatures, lowering of temperatures can help to control it. Critical ‘observation’ points in the system should be determined and checked regularly for rouge.

Rouge does not essentially mean systems be discarded but it calls for justification of continued use of the systems. A periodic observation suffices if rouge is slight and homogeneously distributed in the systems. Removal of rouge should be done if it is localised or concentrated. Manual cleaning, acid pickling, or systemic repassivation help in clearing localized rouge. Such clean ups should be preceded by corrections to the system such as lowering of operating temperature, or removal of nitrogen blankets. It is important to enunciate the detection, management and control of rouge.

Many experienced personnel who have been handling water systems in the industry have viewed rouge with concern but have not confirmed any catastrophic consequences even after several years of use of systems that are adequately managed for rouge. Many adopt a pedantic approach as obtrusive rouge festers water quality. Apprehension about effects of rouge on water quality will however continue to motivate researchers to entail newer processes and procedures for managing rouge.

For more info on the Prescription Pharma Support’s trainings and workshops write to us at pharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Pharmaceutical Water Systems

Event Name : Managing Pharmaceutical Water Systems:  Keep your system  in compliance with regulatory requirements

Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker

Date & Venue : 26-27 July 2010, Holiday Inn Atrium, Singapore

More Info: http://www.pharmasupport.in/latest-pharma-events.html

Contact:Ms. Preetha on (+65) 6562 6708 OR (+65) 9140 7354                                                 OR Email: ppsworkshops@gmail.com

Download:http://bit.ly/bcoK8Q

Rouge in pharmaceutical water systems

July 26th, 2010 by admin No comments »
Retweet

Rouge is a common finding in the storage and distribution channels of water systems. This has raised intimidating concerns in engineering, quality assurance and compliance. Personnel engaged in management of water systems are acquainted to recognize discolorations -red/brown, on the internal, water contact surfaces of stainless steel systems. This causes apprehension and raises alarm. Rouge has been deprecated in the biotechnology and pharmaceutical industries.

Amateurs refer to rouge as ‘rust’ or ‘oxidation corrosion’. Composed of an agglomeration of iron oxides, hydroxides, and other salts (both ferrous and ferric oxidation states) in various hydrated forms, the mixture in rouge depends upon the environment and circumstances. The intricate chemistry gives is various colors like pink, grey, black, red or brown.

The favoured sites for rouge are pump impellors and internal housings, tri-clamp gaskets and valve diaphragms, offtake hoses, machine connections e.g. Nylon/Silicon/PTFE, storage vessel surfaces (usually above the water line), in-line filters and housings, vessel spray balls and still and pure steam generator internals. It has been classified on basis of mechanism of formation.

Though there are many contributors to rouge formation, the final necessary ingredient necessary is heat.  Water systems that operate either wholly or intermittently at temperatures around 80 º C are specifically prone. Rouge calls for further investigation as to faultlessly determine why rouge occurs in pharmaceutical water systems. How does reworking of stainless steel influence rouge and what alternative materials can replace use of stainless steel in future are other concerns. What needs to be done once rouge has been identified in pharmaceutical water systems? The most important next step is to ensure a rigorous QA to demonstrate and document that the same is not changing the output water quality. The continued use of such systems should next be justified by planning a future monitoring of such systems. Absolute removal of rouge, once formed, is not a realistic goal. Remedial actions should be taken to arrest further growth of rouge in water systems.

For more info on the Prescription Pharma Support’s trainings and workshops write to us at pharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Pharmaceutical Water Systems

Event Name : Managing Pharmaceutical Water Systems:  Keep your system  in compliance with regulatory requirements

Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker

Date & Venue : 26-27 July 2010, Holiday Inn Atrium, Singapore

More Info: http://www.pharmasupport.in/latest-pharma-events.html

Contact:Ms. Preetha on (+65) 6562 6708 OR (+65) 9140 7354                                                 OR Email: ppsworkshops@gmail.com

Download:http://bit.ly/bcoK8Q

Pharma Manufacturing: How stainless is steel?

July 23rd, 2010 by admin No comments »
Retweet

Produced in various finishes and textures and tinted over a broad spectrum of colors, steel is a commodity that has a strong association with pharmaceutical manufacturing. Water generators, valves, storage tanks, elbows, fittings, pipes, filters, strainers, wheels, and many more components in water systems are made in steel. Compositions, corrosion properties, cost data, specifications, and categories of steel used in such systems vary according to specific requirements. NSF International has accepted stainless steel in potable water applications. Stainless steel is an accepted material as listed in Appendix “C” of ANSI/NSF Standard #61 “Drinking Water System Components – Health Effects.”

The term ‘stainless’ is now an essential adjective to describe steel. Identified by microstructure or predominant crystal phase, stainless steel is predominantly of three gradesaustenitic, ferritic, and martensitic. Steel, irrespective of its type is desired to be corrosion resistant.  Few understand what makes steel ‘stainless’ and how it is different from ‘corrosion resistance’. Steel will continue to find place in water systems and the quest to understand its types and grades is common to biopharmaceutical and biotechnology industries.

How to make steel ‘stainless’? Addition of a minimum of 12% chromium to the steel that makes it resist rust, or stain ‘less’ than other types of steel. Besides this, nickel, molybdenum, niobium also enhances corrosion resistance of steel. It is incredible to know that sturdy steel is covered by a thin passive invisible film of chrome-containing oxide. The passive film has sustainenace requirements. It is important to know the vulnerability to corrosion in different environments. Many experts are prejudiced that passivation enhances corrosion resistance.

For more info on the Prescription Pharma Support’s trainings and workshops write to us at pharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Pharmaceutical Water Systems

Event Name : Managing Pharmaceutical Water Systems:  Keep your system  in compliance with regulatory requirements

Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker

Date & Venue : 26-27 July 2010, Holiday Inn Atrium, Singapore

More Info: http://www.pharmasupport.in/latest-pharma-events.html

Contact:Ms. Preetha on (+65) 6562 6708 OR (+65) 9140 7354                                                 OR Email: ppsworkshops@gmail.com

Download:http://bit.ly/bcoK8Q

Process Analytical Technology (PAT): Is the industry underusing PAT tools?

July 23rd, 2010 by admin 4 comments »
Retweet

The FDA’s positive and encouraging initiatives to ensure that quality is inbuilt in process is clearly revealed in PAT. The guidance for industry “PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance” has been a welcome response from some in pharmaceutical and biotechnology industry. Many are yet to brave the adoption of online TOC analyzers. Releasing water based on automated process control is an economical and effective way to achieve TOC regulatory compliance. It is a regulatory respite to both the industry and the FDA.  Estimates state that around 2500 water loops worldwide are candidates for online TOC analysis. By converting to online analysis, the industry will positively reciprocate to the regulatory initiative for automation to ease validation and inspection. It is important to gain a foresight into the impact of FDA on use of online analyzers in the years to come. There are some who have converted into online analyzers in water systems. Some have supplemented the laboratory analyzers with online ones and some are still planning to convert. This approach is not a pedantry or flaunt of alacrity. The FDA entails PAT for quality as it is scientifically, operationally and economically sound. There is a need for vigorously introducing it to the industry.

For more info on the Prescription Pharma Support’s trainings and workshops write to us at pharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Pharmaceutical Water Systems

Event Name : Managing Pharmaceutical Water Systems:  Keep your system  in compliance with regulatory requirements

Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker

Date & Venue : 26-27 July 2010, Holiday Inn Atrium, Singapore

More Info: http://www.pharmasupport.in/latest-pharma-events.html

Contact:Ms. Preetha on (+65) 6562 6708 OR (+65) 9140 7354                                                 OR Email: ppsworkshops@gmail.com

Download:http://bit.ly/bcoK8Q

TOC automation: possible strategies

July 16th, 2010 by admin No comments »
Retweet

To meet the requirements of the USP for water monographs, many companies have implemented use of online conductivity and TOC process analyzers. These companies have embraced the change from manual to automated systems and have vaunted economic benefits. Automation of TOC and conductivity measurements has imbued many to install and use them for quality. More and more companies are now beginning to study the FDA cGMP philosophies and are inquisitive about designing systems for automatic water release. Blatantly evident is the requirement to reckon for these systems. The aspirants for knowledge, who are directly or indirectly involved in management of water systems in pharmaceutical  and biotechnology industries can attend the upcoming conference in Singapore. The 2 day event being organized by Prescription Pharma Support is an opportunity to learn more about the seemingly exigent strategies for TOC in water systems. The event will invite stalwarts to share the experiences from past and new installations of TOC. A robust requirement in any TOC analyzer is that measurements should b representative of the TOC at the point-of-use. The participants can learn more about the possible placement locations of on-line TOC analyzers with the ozonated and non-ozonated distribution loops. The new beginners can learn how to select the lowest capital expense approach. Members need to be induced for the conscientious transition from laboratory TOC analyzers to online TOC analyzers as personnel are more trained in the former and may resist the change.   Many companies have installed online analyzers are also having laboratory grab sample analysis as a backup. When using both, it is even more desirable to know the depths of how to avoid variances and intelligently interpret the differences in the two, if encountered. Enunciated by the USP and EP, water systems management has earned incredulous thoughtful planning from many companies. Many have adopted the dual online TOC approach. This has scored over the single analyzer approach. It is important to know how to decide the critical points of placement of more than one analyzers and how to ensure the points chosen are able to meet the requirements of TOC. The conference is rightly envisaged as an opportunity to build a comprehensive management system for proper implementation of an automated real time TOC release system. For this the participants will be able to learn how to integrate the process analytical instruments, computers, data acquisition, and other process equipments. Many progressive companies that have implemented continual operations of the process according to GAMP guidelines to ensure product quality. The conference is an excellent opportunity to learn from their experiences. Thus, this event is likely to attract all personnel engaged in water systems design, ongoing maintenance, laboratory testing, production, quality assurance, validation and qualification, operation and monitoring, regulatory affairs and projects and engineering. Participation of teams in events like these is truly rewarding.

For more info on the Prescription Pharma Support’s trainings and workshops write to us at pharmasupport@gmail.com or visit www.pharmasupport.in or Follow us on www.twitter.com/PharmaSupportIN or http://in.linkedin.com/pub/nikhil-nagri/21/b7a/b09. You can also call us at +912229678560 – 61

Upcoming Events on Pharmaceutical Water Systems

Event Name : Managing Pharmaceutical Water Systems:  Keep your system  in compliance with regulatory requirements

Speakers : Neil Grumbridge (former Head of Quality and Safety, Health Protection Agency, UK) and Mr. Pravin Manker

Date & Venue : 26-27 July 2010, Holiday Inn Atrium, Singapore

More Info: www.pharmasupport.in/latest-pharma-events.html

Contact:Ms. Preetha on (+65) 6562 6708 OR (+65) 9140 7354                                                 OR Email: ppsworkshops@gmail.com

Download:http://bit.ly/bcoK8Q

Get Adobe Flash playerPlugin by wpburn.com wordpress themes